Skip to main content
Top

01-10-2019 | Non-small-cell lung cancer | Video | Article

Researcher comment: Take-home messages from the CheckMate 227 trial

print
PRINT
insite
SEARCH

Solange Peters discusses the implications of the CheckMate 227 findings for the front-line treatment of advanced non-small-cell lung cancer and outlines the key next steps (3:45).

Read the transcript

print
PRINT